Polymicrobial dynamics in transfer of vancomycin resistance to MRSA

万古霉素耐药性向 MRSA 转移的多微生物动力学

基本信息

  • 批准号:
    8655516
  • 负责人:
  • 金额:
    $ 5.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-06-01 至 2015-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Methicillin resistant S. aureus (MRSA) are leading causes of antibiotic resistant infection, treated mainly with vancomycin. Since 2002, VanA-type vancomycin resistance has moved on plasmids from vancomycin resistant enterococci (VRE) to MRSA, forming VRSA. This has happened at least 12 times independently during the course of infection, mainly in lesions on the extremities of diabetics. All S. aureus recipients of the vancomycin resistance transposon have been of a single S. aureus clade, CC5. For horizontal transmission to occur, VRE and MRSA must occupy the same environment in sufficient number and proximity for transfer to occur. I hypothesize that CC5 MRSA and VRE exhibit unique interactions compared to other MRSA lineages, which include cooperative metabolic abilities promoting synergy, co-aggregation with host-derived factors, and modulation of intra- and interspecies cell signaling. Preliminary data identified serum-dependent co-aggregation as being unique to CC5-MRSA and VRE pairs. To determine what affects multi-species binding, purified serum components will be added to co-cultures and co-aggregation will be assayed by microscopy and optical density. Any enhancement of horizontal transmission will be quantified by selective plating of MRSA recipients after co-culture with enterococci containing a resistance plasmid. I have found down-regulation of VRE genes for pheromone signaling and the fsr virulence operon in the transcriptome responses of VRE /MRSA in co-culture. The impact of cell signaling modulation will be studied by transcriptomics and targeted mutagenesis of the putative pheromone signal revealed by our microarray data. D-lactate (dLac) is commonly produced by S. aureus during fermentation. dLac is also necessary for VanA-type vancomycin resistance. As VanA type resistance is induced only when vancomycin is present, I hypothesize that S. aureus dLac production may provide an advantage to VRE in co-culture with S. aureus. This will be tested by measuring survival of both species in co- and mono-culture after vancomycin exposure as well as VRE in mono-culture incubated with dLac prior to vancomycin treatment. These results will ultimately reveal the nature of polymicrobial interactions specific to ST5-MRSA and VRE and how they lead to vancomycin resistance transfer.
描述(申请人提供):耐甲氧西林金黄色葡萄球菌(MRSA)是抗生素耐药感染的主要原因,主要使用万古霉素治疗。自2002年以来,VANA型万古霉素耐药从耐万古霉素肠球菌(VRE)转移到MRSA,形成VRSA。在感染过程中,这种情况至少独立发生了12次,主要发生在糖尿病患者的肢体皮损中。所有接受万古霉素耐药转座子的金黄色葡萄球菌都是一株金黄色葡萄球菌,CC5。要进行水平传播,VRE和MRSA必须以足够的数量和距离占据相同的环境才能进行传输。我推测,与其他MRSA谱系相比,CC5 MRSA和VRE表现出独特的相互作用,包括促进协同作用的协同代谢能力,与宿主衍生因子的共同聚集,以及对种内和种间细胞信号的调节。初步数据证实,血清依赖的共聚集是CC5-MRSA和VRE对所特有的。为了确定是什么影响多物种结合,纯化的血清成分将被添加到共培养中,并通过显微镜和光密度分析共聚集。任何水平传播的增强都将通过与含有耐药质粒的肠球菌共培养后对MRSA接受者进行选择性培养来量化。我发现在VRE/MRSA共培养的转录组反应中,VRE基因对信息素信号和FSR毒力操纵子的下调。细胞信号调节的影响将通过转录和我们的微阵列数据揭示的信息素信号的定向突变来研究。D-乳酸(DLac)通常由金黄色葡萄球菌在发酵过程中产生。DLac对VANA型万古霉素耐药也是必需的。由于VANA型耐药性只有在万古霉素存在的情况下才被诱导,我推测金黄色葡萄球菌dLac的产生在与金黄色葡萄球菌共培养时可能为VRE提供优势。这将通过测量万古霉素暴露后两个物种在共培养和单一培养中的存活率以及在万古霉素治疗之前与dLac孵育的单一培养中的VRE来进行测试。这些结果将最终揭示ST5-MRSA和VRE所特有的多菌相互作用的性质以及它们如何导致万古霉素耐药性转移。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Matthew Ramsey其他文献

Matthew Ramsey的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Matthew Ramsey', 18)}}的其他基金

Mechanisms underlying spatial interaction in the oral microbiota
口腔微生物群空间相互作用的潜在机制
  • 批准号:
    10180938
  • 财政年份:
    2019
  • 资助金额:
    $ 5.33万
  • 项目类别:
Mechanisms underlying spatial interaction in the oral microbiota
口腔微生物群空间相互作用的潜在机制
  • 批准号:
    10653199
  • 财政年份:
    2019
  • 资助金额:
    $ 5.33万
  • 项目类别:
Mechanisms underlying spatial interaction in the oral microbiota
口腔微生物群空间相互作用的潜在机制
  • 批准号:
    9816352
  • 财政年份:
    2019
  • 资助金额:
    $ 5.33万
  • 项目类别:
Mechanisms underlying spatial interaction in the oral microbiota
口腔微生物群空间相互作用的潜在机制
  • 批准号:
    10215687
  • 财政年份:
    2019
  • 资助金额:
    $ 5.33万
  • 项目类别:
Mechanisms underlying spatial interaction in the oral microbiota
口腔微生物群空间相互作用的潜在机制
  • 批准号:
    9974507
  • 财政年份:
    2019
  • 资助金额:
    $ 5.33万
  • 项目类别:
Mechanisms underlying spatial interaction in the oral microbiota
口腔微生物群空间相互作用的潜在机制
  • 批准号:
    10408065
  • 财政年份:
    2019
  • 资助金额:
    $ 5.33万
  • 项目类别:
Polymicrobial dynamics in transfer of vancomycin resistance to MRSA
万古霉素耐药性向 MRSA 转移的多微生物动力学
  • 批准号:
    8721616
  • 财政年份:
    2012
  • 资助金额:
    $ 5.33万
  • 项目类别:
Polymicrobial dynamics in transfer of vancomycin resistance to MRSA
万古霉素耐药性向 MRSA 转移的多微生物动力学
  • 批准号:
    8519048
  • 财政年份:
    2012
  • 资助金额:
    $ 5.33万
  • 项目类别:
Polymicrobial dynamics in transfer of vancomycin resistance to MRSA
万古霉素耐药性向 MRSA 转移的多微生物动力学
  • 批准号:
    8396810
  • 财政年份:
    2012
  • 资助金额:
    $ 5.33万
  • 项目类别:
How interactions of oral bacteria enhance resistance to innate immunity
口腔细菌的相互作用如何增强对先天免疫的抵抗力
  • 批准号:
    7847475
  • 财政年份:
    2009
  • 资助金额:
    $ 5.33万
  • 项目类别:

相似海外基金

Ecological and Evolutionary Drivers of Antibiotic Resistance in Patients
患者抗生素耐药性的生态和进化驱动因素
  • 批准号:
    EP/Y031067/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.33万
  • 项目类别:
    Research Grant
Collaborative Research: Leveraging the interactions between carbon nanomaterials and DNA molecules for mitigating antibiotic resistance
合作研究:利用碳纳米材料和 DNA 分子之间的相互作用来减轻抗生素耐药性
  • 批准号:
    2307222
  • 财政年份:
    2024
  • 资助金额:
    $ 5.33万
  • 项目类别:
    Standard Grant
Molecular Epidemiology of Antibiotic Resistance in Clostridioides difficile
艰难梭菌抗生素耐药性的分子流行病学
  • 批准号:
    502587
  • 财政年份:
    2024
  • 资助金额:
    $ 5.33万
  • 项目类别:
Collaborative Research: Leveraging the interactions between carbon nanomaterials and DNA molecules for mitigating antibiotic resistance
合作研究:利用碳纳米材料和 DNA 分子之间的相互作用来减轻抗生素耐药性
  • 批准号:
    2307223
  • 财政年份:
    2024
  • 资助金额:
    $ 5.33万
  • 项目类别:
    Standard Grant
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
  • 批准号:
    MR/Y013131/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.33万
  • 项目类别:
    Research Grant
Determining structural dynamics of membrane proteins in their native environment: focus on bacterial antibiotic resistance
确定膜蛋白在其天然环境中的结构动力学:关注细菌抗生素耐药性
  • 批准号:
    MR/X009580/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.33万
  • 项目类别:
    Fellowship
CAREER: Systems Microbiology and InterdiscipLinary Education for Halting Environmental Antibiotic Resistance Transmission (SMILE HEART)
职业:阻止环境抗生素耐药性传播的系统微生物学和跨学科教育(SMILE HEART)
  • 批准号:
    2340818
  • 财政年份:
    2024
  • 资助金额:
    $ 5.33万
  • 项目类别:
    Continuing Grant
Reinforcing the battle at the bacterial cell wall: Structure-guided characterization and inhibition of beta-lactam antibiotic resistance signalling mechanisms
加强细菌细胞壁的战斗:β-内酰胺抗生素耐药信号机制的结构引导表征和抑制
  • 批准号:
    480022
  • 财政年份:
    2023
  • 资助金额:
    $ 5.33万
  • 项目类别:
    Operating Grants
The spread of antibiotic resistance in bacteria-plasmid networks
抗生素耐药性在细菌-质粒网络中的传播
  • 批准号:
    BB/X010473/1
  • 财政年份:
    2023
  • 资助金额:
    $ 5.33万
  • 项目类别:
    Fellowship
An RNA Nanosensor for the Diagnosis of Antibiotic Resistance in M. Tuberculosis
用于诊断结核分枝杆菌抗生素耐药性的 RNA 纳米传感器
  • 批准号:
    10670613
  • 财政年份:
    2023
  • 资助金额:
    $ 5.33万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了